| Entries |
| Document | Title | Date |
|---|
| 20080207751 | Sulindac Derivatives for Treatment of Cancer - The present invention relates to novel non steroidal anti-inflammatory compounds (NSAIDs) derivatives of sulindac, for the treatment/prevention, alone or in combination, of cancer. | 08-28-2008 |
| 20080234370 | Calcilytic Compounds - Novel calcilytic compounds and methods of using them are provided. | 09-25-2008 |
| 20080249167 | Compounds and methods for delivery of prostacyclin analogs - This invention pertains generally to prostacyclin analogs and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis. Generally, the compounds and methods of the present invention increase the oral bioavailability and circulating concentrations of treprostinil when administered orally. Compounds of the present invention have the following formula: | 10-09-2008 |
| 20080280978 | Insect Repellent Compositions - An insect repellent composition containing 3,8-p-menthane-diol and benzylbenzoate as active compounds is described. Typically, the active compounds are each present in the composition in an amount which is less than an amount of the compound required to be effective as an insect repellent by itself. The composition may additionally include one or more additional active compounds selected from the group consisting of 2-butyl-2-ethyl-1,3-propanediol, 2-ethyl-1,3hexanediol and 5-N-butylacetanilide. One or more promoters, carriers, diluents, dispersants, solvents, emollients, emulsifiers, colouring agents, fragrances or thickening agents may also be included in the composition. | 11-13-2008 |
| 20080319067 | 2-Hydroxy-6-phenylphenanthridines as PDE-4 inhibitors - The compounds of formula I | 12-25-2008 |
| 20090062384 | NOVEL ABIETANE DITERPENOID COMPOUND, AND COMPOSITION COMPRISING EXTRACT OF TORREYA NUCIFERA, OR ABIETANE DITERPENOID COMPOUNDS OR TERPENOID COMPOUNDS ISOLATED FROM THEM FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE - The present invention relates to a composition for the prevention and the treatment of cardiovascular disease containing extracts of | 03-05-2009 |
| 20090076142 | USE OF THE IRRITATING PRINCIPAL OLEOCANTHAL IN OLIVE OIL, AS WELL AS STRUCTURALLY AND FUNCTIONALLY SIMILAR COMPOUNDS - The invention provides methods of synthesizing the purified enantiomers of oleocanthal. The invention further provides methods of using oleocanthals in various formulations including, food additives; pharmaceuticals; cosmetics; animal repellants; and discovery tools for mammalian irritation receptor genes, gene products, alleles, splice variants, alternate transcripts and the like. | 03-19-2009 |
| 20090221701 | Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure - The use of fibrates, particularly clofibrate, is described for the preparation of a medicament useful in the treatment of congestive heart failure. | 09-03-2009 |
| 20100004331 | ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS - Described herein are compounds that are antagonists of PGD | 01-07-2010 |
| 20100076078 | INSECTICIDAL COMPOUNDS - Novel compounds of formula (I): wherein A | 03-25-2010 |
| 20100093853 | USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA - The present invention provides the use of (−)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid derivatives and compositions in the treatment of insulin resistance, Type 2 diabetes and hyperlipidemia. | 04-15-2010 |
| 20100137433 | Production of Rosmarinic Acid from Spearmint and uses Thereof - The present invention provides plants and plant tissues of spearmint ( | 06-03-2010 |
| 20100152290 | Benzo Lipoxin Analogues - Benzolipoxin analogs, methods of their preparation and pharmaceutical compositions containing the compounds are provided. The compounds and compositions are useful in methods for treatment of various diseases, including, inflammation, autoimmune disease and abnormal cell proliferation. | 06-17-2010 |
| 20100160432 | Curative drug for neurodegenerative diseases - A compound is prepared based on Formula 1: | 06-24-2010 |
| 20100160433 | TREATMENT OF NEURODEGENERATIVE AND CARDIOVASCULAR DISORDERS - A method of treating a neurodegenerative or cardiovascular disorder with a compound of the following formula: | 06-24-2010 |
| 20100261789 | Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes - The present invention relates to butenoic acid derivatives of the formula I: | 10-14-2010 |
| 20100331409 | Use of Methyl Cinnamate in the Inhibition of Candida Albicans Biofilms - The invention provides a method of inhibiting biofilm formation or development of | 12-30-2010 |
| 20110015265 | METHOD FOR CONTROLLING DISEASES ON TURFGRASS - The present invention provides a method for controlling diseases on turfgrass which comprises applying to turfgrass that has been cut back an effective amount of a compound of formula ( | 01-20-2011 |
| 20110275712 | Oil In Water Emulsion Cosmetic Composition For Skin - An oil in water emulsion cosmetic composition for skin, in which vitamin A and its derivatives are stably incorporated and which has superior feeling in use (skin familiarity or feeling of skin absorption, feeling of efficacy after application) and base composition stability (emulsion stability) with the passage of time. The oil in water emulsion cosmetic composition for skin comprises, relative to the total amount of the cosmetic composition, (a) from 0.01 to 4% by mass of vitamin A and its derivative, (b) from 0.6 to 4% by mass of a nonionic surfactant comprising three of (b-1) sorbitan tristearate, (b-2) polyethylene glycol stearate with from 20 to 120 mols of polyethylene glycol added thereto, (b-3) glyceryl stearate having an HLB of from 5 to 8, and (c) from 1 to 10% by mass of a higher alcohol having from 14 to 24 carbon atoms, wherein the blend ratio (by mass) of component (b-1) to component (b) is from 0.1 to 0.8. | 11-10-2011 |
| 20120142772 | Benzo Lipoxin Analogues - Benzolipoxin analogs, methods of their preparation and pharmaceutical compositions containing the compounds are provided. The compounds and compositions are useful in methods for treatment of various diseases, including, inflammation, autoimmune disease and abnormal cell proliferation. | 06-07-2012 |
| 20130053441 | NOVEL ESTER DERIVATIVE AND USE THEREOF - A compound represented by the following formula (I′) | 02-28-2013 |
| 20130237599 | COMPOUNDS AND USES THEREOF FOR TREATING INFLAMMATION AND MODULATING IMMUNE RESPONSES - The present invention provides compounds, and compositions comprising these compounds, which have immunomodulatory activity and/or anti-inflammatory activity. | 09-12-2013 |
| 20130324605 | USES OF CIMIRACEMATE A AND RELATED COMPOUNDS FOR TREATING INFLAMMATION AND MODULATING IMMUNE RESPONSES - The present invention pertains to Cimiracemate A and related compounds that are useful as inhibitors of 5-lipoxygenase (5-1. OX) activity and various proinflammatory mediators such as lipoxins, leukotrienes (e.g., LTA4, LTB4, LTC4, LTD4, and LTE4), prostaglandins, and thromboxanes. The present invention also provides therapeutic methods and compositions for treatment of inflammation and inflammatory conditions, including allergenic reactions, diseases associated with cell proliferation, neoangiogenesis, and cardiovascular diseases. | 12-05-2013 |
| 20140249219 | Anti-obesity potential of Calebin A - The present invention discloses the potential of Calebin A in inhibiting adipogenesis and applications thereof in obesity management. The present invention elucidates the potential of Calebin A to favorably modulate biochemical markers associated with obesity. Notable biomodulatory properties of Calebin A include inhibiting leptin production, increasing adiponectin expression and inhibiting local (adipocyte) and systemic inflammation caused by pro-inflammatory cytokines Tumor Necrosis Factor (TNF-α), Interleukin-6 (IL-6) and Interleukin-1 (IL-1β). | 09-04-2014 |
| 20150073047 | Benzo Lipoxin Analogues - Benzolipoxin analogs, methods of their preparation and pharmaceutical compositions containing the compounds are provided. The compounds and compositions are useful in methods for treatment of various diseases, including, inflammation, autoimmune disease and abnormal cell proliferation. | 03-12-2015 |
| 20160000743 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF OPHALMIC DISEASES AND DISORDERS - This invention provides compounds, methods and compositions for the treatment of ophthalmic diseases and disorders, including retinal and choroidal disorders and related conditions. More particularly, the invention provides a method of using the provided pharmaceutical compositions for the treatment of ophthalmic diseases and disorders, including retinal and choroidal diseases, and related conditions, upon topical administration to the eye. | 01-07-2016 |
| 20160128926 | COMPOSITIONS AND METHODS FOR TREATING NAILS, CLAWS, AND HOOFS - The present approach relates to compositions and methods for treating fingernails, toenails, hoofs, claws and the like, in mammals. More particularly, the present approach relates to compositions and methods including a prostaglandin analog active ingredient and a carrier. The compositions and methods may be used for increasing the thickness, strength, integrity, length and/or growth rate of human nails, or both, and promoting healthy nail growth and appearance, as well as relates to compositions and methods for increasing the thickness or strength of horny parts of mammals, and promoting healthy nail, claw and hoof growth. | 05-12-2016 |
| 20160193176 | CHLOROGENIC ACID POWDER-INJECTION AND PREPARATION METHOD THEREOF | 07-07-2016 |
| 20180022688 | COMPOUND, AND SEPARATION METHOD, SYNTHESIS METHOD AND USE THEREOF | 01-25-2018 |
